Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kudo, Yuma"'
Autor:
Kudo, Yuma1 (AUTHOR), Suzuki, Hiroyuki1,2 (AUTHOR) hiroyuki.suzuki.b4@tohoku.ac.jp, Tanaka, Tomohiro1,2 (AUTHOR), Kaneko, Mika K.1,2 (AUTHOR), Kato, Yukinari1,2 (AUTHOR) hiroyuki.suzuki.b4@tohoku.ac.jp
Publikováno v:
Antibodies (2073-4468). Jun2023, Vol. 12 Issue 2, p31. 16p.
Autor:
Suzuki, Hiroyuki, Tanaka, Tomohiro, Kudo, Yuma, Tawara, Mayuki, Hirayama, Aoi, Kaneko, Mika K., Kato, Yukinari
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Dec2023, Vol. 42 Issue 6, p203-208, 6p
Autor:
Suzuki, Hiroyuki, Kudo, Yuma, Tawara, Mayuki, Goto, Nohara, Ishikawa, Kenichiro, Ouchida, Tsunenori, Tanaka, Tomohiro, Asano, Teizo, Nakamura, Takuro, Yanaka, Miyuki, Kaneko, Mika K., Kato, Yukinari
CD39 is involved in adenosine metabolism through conversion of extracellular ATP to adenosine. Because extracellular adenosine plays a critical role in the immune suppression of tumor microenvironment, the inhibition of CD39 activity by monoclonal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=sharePrprorg::748843fe0a68ea5e0d900bd54e27e02f
Epitope Mapping of the Novel Anti-Human CCR9 Monoclonal Antibody (C9 Mab-11) by 2 × Alanine Scanning.
Autor:
Isoda, Yu, Tanaka, Tomohiro, Suzuki, Hiroyuki, Asano, Teizo, Kitamura, Kaishi, Kudo, Yuma, Ejima, Ryo, Ozawa, Kazuki, Yoshikawa, Takeo, Kaneko, Mika K., Kato, Yukinari
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Apr2023, Vol. 42 Issue 2, p73-76, 4p
Autor:
Isoda, Yu, Tanaka, Tomohiro, Suzuki, Hiroyuki, Asano, Teizo, Yoshikawa, Takeo, Kitamura, Kaishi, Kudo, Yuma, Ejima, Ryo, Ozawa, Kazuki, Kaneko, Mika K., Kato, Yukinari
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Feb2023, Vol. 42 Issue 1, p22-26, 5p
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Aug2022, Vol. 41 Issue 4, p194-201, 8p
Autor:
Suzuki, Hiroyuki, Saito, Masaki, Asano, Teizo, Tanaka, Tomohiro, Kitamura, Kaishi, Kudo, Yuma, Kaneko, Mika K., Kato, Yukinari
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Apr2022, Vol. 41 Issue 2, p110-114, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Isoda Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan., Tanaka T; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan., Suzuki H; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan., Asano T; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan., Kitamura K; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan., Kudo Y; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan., Ejima R; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan., Ozawa K; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan., Yoshikawa T; Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan., Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan., Kato Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2023 Apr; Vol. 42 (2), pp. 73-76.
Autor:
Isoda Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Tanaka T; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Suzuki H; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Asano T; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Yoshikawa T; Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Kitamura K; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Kudo Y; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Ejima R; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Ozawa K; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Kato Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.; Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2023 Feb; Vol. 42 (1), pp. 22-26. Date of Electronic Publication: 2022 Nov 16.